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doi:10.1016/j.jmii.2011.01.016Abstract Kawasaki disease (KD) is an acute febrile multisystem vasculitic syndrome of
unknown etiology, occurring mostly in infants and children younger than 5 years of age. We
present a 13-month-old male with KD from whom was found human bocavirus DNA in nasopha-
ryngeal secretions. Human bocavirus DNA in a patient with KD raised question about the coin-
cidental or possible etiological association.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
The cause of Kawasaki disease (KD) is unclear and there is
no specific method of diagnosis; clinical suspicion is based
on the identification of defined clinical criteria.1 KD is
a multisystemic vasculitis of small to medium size
vessels.1,2 The natural history of KD reveals that coronary
artery aneurysms occur as a sequel of the vasculitis in 20%
to 25% of untreated children. Although the cause of KD
remains unknown, clinical trials have established effective
therapies, despite the absence of a proven cause. Intra-
venous immunoglobulin plus aspirin lowers the rate of.S. Nogueira).
an Society of Microbiology. Publcoronary artery aneurysms from 20% to between 3% and
5%.3
Immunopathological mechanisms involved in the patho-
genesis of KD are unclear. Although its etiology remains
unknown, the clinical and epidemiological features of this
disease suggest that it is infectious.1,4 Epstein-Barr virus,
adenovirus, and cytomegalovirus have all been considered
as possible agents that are involved in KD.5,6 The recently
discovered human bocavirus (HBoV) is the first member of
the family Parvoviridae, genus Bocavirus, to be potentially
associated with human disease.7 Several studies have
identified HBoV in respiratory specimens from children with
acute respiratory disease but the full spectrum of clinical
disease and the epidemiology of HBoV infection remain
unclear.8,9,10 A study using nasopharyngeal aspirates from
children hospitalized with fever also revealed HBoV nucleic
acid in five patients hospitalized with KD.2ished by Elsevier Taiwan LLC. All rights reserved.
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A 13-month-old male child, previously healthy, with upda-
ted vaccination, including antimeningococcal and anti-
pneumococcal vaccine, was admitted to our hospital on
October 2006 after 5 days of fever because of a suspicion of
KD. Fig. 1.
On Day 1, he had fever with rash (on trunk and limbs)
and presented with leukocytosis, neutrophilia, and
elevated C-reactive protein (4.0 mg/dL). A progressive
worsening of the general state was verified; and on Day 4,
he was treated with ampicilin (80 mg/kg/d, 6/6 hours). On
Day 5, he maintained fever; irritability; and developed
mouth enanthem, glossitis, rash with perioral desquama-
tion, swelling of the hands and feet, conjunctivitis, and
jaundice. On clinical examination, he had tachycardia,
systolic murmur, and hepatomegaly. Laboratory evaluation
at admission in our hospital, on Day 5, showed 15,860/mL
leukocyte count with 15.3% neutrophils, hemoglobin
10.3 g/dL, platelet count 225,000/mL, C-reactive protein
13.7 mg/dL, and elevation of transaminase (63/86 UI/L).
Renal function, cultures (blood, urine, and feces), and
serology for adenovirus, cytomegalovirus, Epstein-Barr
virus, and parvovirus B19 were within normal limits or
negatives.
Chest X-ray revealed a bibasal nonspecific interstitial
infiltrate. Echocardiography (Day 2) showed a slight mitral
valve insufficiency and normal coronary arteries; and on
Day 6, left coronary aneurysm was identified (Fig. 1), which
confirmed the diagnosis of KD. Detection of adenovirus,
influenza virus A and B, parainfluenza virus 1e3, and
respiratory syncytial virus in nasopharyngeal secretions by
an immunofluorescence were negative. HBoV was identified
in nasopharyngeal secretions by real time polymerase chain
reaction (PCR) followed by sequencing of PCR product.
Treatment with gammaglobulin (2 g/kg) in a single dose
and high dose of diary antiplatelet aggregate led to rapid
resolution without relapse, progressive normalization of the
liver function, and transitional thrombocytosis. Cardiac
outcome was excellent with resolution of coronary
aneurysm.Figure1. Coronary echocardiography showing a left aneurysm.Discussion
During the past 30 years, identifying of a definitive infec-
tious agent that causes KD has not been possible. Certain
intracellular pathogens and superantigens from bacteria
have been implicated in its immunopathogenesis. Several
lines of evidence support the fact that KD is an infectious
disease, such as acute onset of a self-limited illness, pres-
ence of fever, increased susceptibility in younger age
groups, and geographic clustering of outbreaks with
a seasonal predominance (later winter and early spring).
Various bacteria, such as Streptococcus pyogenes, Staphy-
lococcus aureus, Mycoplasma pneumoniae, and Chlamydo-
phila pneumoniae have been sporadically isolated from
patients with KD. Suspected viral agents, especially lym-
photrophic viruses, such as adenovirus, Epstein-Barr virus,
parvovirus B19, herpesvirus 6, parainfluenza type 3 virus,
human immunodeficiency virus, measles virus, rotavirus,
dengue virus, and varicella-zoster virus have been impli-
cated as potential causes of KD, but no proof has emerged
to incriminate one agent.11
This new parvovirus, genus Bocavirus (HBoV), has been
identified in nasopharyngeal secretions from children with
acute febrile respiratory infection. The potential of causing
other nonrespiratory diseases has been under discussion.12,13
Later publications reported the virus in the gastrointestinal
tract and serum, referring to a systemic dissemination.14,15
The detection of HBoV DNA in a patient with KD raised
question about the coincidental or possible etiological asso-
ciation. Based on the clinical, epidemiological, and immu-
nological features of KD, the pathogenesis of KD could be
a hyperimmune reaction in genetically susceptible children
to a ubiquitous virus. Catalano-Pons et al.2 have also iden-
tified HBoV by PCR in five (31.2%) patients with KD, sug-
gesting that this emerging virus may also play a pathogenic
role in some cases of KD. Additional studies are required to
understand the physiopathology of this new virus.References
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